Growth Metrics

Jazz Pharmaceuticals (JAZZ) Enterprise Value (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Jazz Pharmaceuticals 14.64 Bn 12.79 Bn 934.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -32.50%
Dec 31, 2025 -4.96%
Sep 30, 2025 -11.45%
Jun 30, 2025 36.09%
Mar 31, 2025 22.83%
Dec 31, 2024 -8.78%
Sep 30, 2024 -63.60%
Jun 30, 2024 6.07%
Mar 31, 2024 4.18%
Dec 31, 2023 -12.77%
Sep 30, 2023 -4.16%
Jun 30, 2023 -9.79%
Mar 31, 2023 -32.49%
Dec 31, 2022 -5.02%
Sep 30, 2022 -18.01%
Jun 30, 2022 -44.91%
Mar 31, 2022 17.01%
Dec 31, 2021 11.96%
Sep 30, 2021 24.64%
Jun 30, 2021 57.50%
Mar 31, 2021 -98.30%
Dec 31, 2020 -42.57%
Sep 30, 2020 5.62%
Jun 30, 2020 -12.04%
Mar 31, 2020 -10.08%
Dec 31, 2019 19.85%
Sep 30, 2019 -24.69%
Jun 30, 2019 -16.49%
Mar 31, 2019 -76.82%
Dec 31, 2018 37.95%
Sep 30, 2018 -2.87%
Jun 30, 2018 -7.04%
Mar 31, 2018 -17.39%
Dec 31, 2017 14.71%
Sep 30, 2017 -41.79%
Jun 30, 2017 21.57%
Mar 31, 2017 4.45%
Dec 31, 2016 0.01%
Sep 30, 2016 53.51%
Jun 30, 2016 6.54%
Mar 31, 2016 0.83%
Dec 31, 2015 1.01%
Sep 30, 2015 -8.38%
Jun 30, 2015 -17.77%
Mar 31, 2015 -14.41%
Dec 31, 2014 -18.96%
Sep 30, 2014 -114.65%
Jun 30, 2014 -17.35%
Mar 31, 2014 64.14%
Dec 31, 2013 -8.16%
Sep 30, 2013 -16.69%
Jun 30, 2013 -11.94%
Mar 31, 2013 -16.35%
Dec 31, 2012 -104.01%
Sep 30, 2012 -22.81%
Jun 30, 2012 36.72%
Mar 31, 2012 -54.67%
Dec 31, 2011 -39.30%
Sep 30, 2011 -10.70%
Jun 30, 2011 -57.38%
Mar 31, 2011 -45.24%
Dec 31, 2010 -96.01%
Sep 30, 2010 -138.70%